Video Experimental Relacionado
Updated: Jul 28, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Predicción de las necesidades de warfarina de los pacientes
Lancet (London, England)
|October 22, 1977
Resumen
La terapia anticoagulante con warfarina requiere una dosificación cuidadosa. Un estudio encontró una estrecha relación entre la respuesta inicial al Thrombotest y la dosis de mantenimiento, lo que permite la predicción de la dosis para los pacientes con warfarina.
Área de la Ciencia:
- Farmacología Farmacología.
- La medicina clínica es la medicina clínica.
- Investigación de la trombosis.
Sus antecedentes:
- La warfarina es un anticoagulante ampliamente utilizado.
- Un tratamiento eficaz con warfarina requiere una dosificación precisa para equilibrar la eficacia y el riesgo de sangrado.
- El monitoreo de la respuesta anticoagulante es crucial para el manejo del paciente.
Objetivo del estudio:
- Investigar la relación entre la respuesta inicial a la warfarina y la dosis de mantenimiento a largo plazo.
- Para determinar si la respuesta inicial al Thrombotest puede predecir las dosis de mantenimiento requeridas de warfarina.
Principales métodos:
- Se estudiaron 34 pacientes sometidos a tratamiento con warfarina.
- Se administró una dosis de carga de 10 mg/día de warfarina durante tres días.
- El logaritmo de la respuesta del "Thrombotest" a la dosis de carga se correlacionó con la dosis de mantenimiento necesaria para una respuesta del 8-12% en la prueba de trombosis.
Principales resultados:
- Se observó una estrecha relación entre el logaritmo de la respuesta inicial al Thrombotest y la dosis de mantenimiento requerida de warfarina.
- Esta correlación sugiere la previsibilidad de las dosis de mantenimiento basadas en la respuesta temprana.
Conclusiones:
- La respuesta inicial de la prueba de trombosis a una dosis de carga de warfarina puede predecir la dosis de mantenimiento requerida para la anticoagulación terapéutica.
- Esta relación predictiva puede ayudar a optimizar las estrategias de dosificación de warfarina.
Videos de Conceptos Relacionados
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:25Dosage Regimen: Multiple Oral Dosage
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...